ÂÜÀòÂÒÂ×

Bruce Pritchard is a seasoned executive with extensive leadership experience in the biotechnology and academic sectors. Currently serving as Chief Executive Officer at Caledon Bioscience Inc. and Liminal BioSciences since September 2006, Bruce Pritchard also holds the position of Chair of Court at Heriot-Watt University and will begin as Trustee and Chair of Audit & Risk Committee at the Rosalind Franklin Institute in September 2024. Previous roles include Chair of the Board at Porton Biopharma Ltd., and senior positions at ProMetic Life Sciences Inc. and Imanova Limited. Bruce Pritchard's professional affiliations include various leadership roles at ICAS, and significant contributions to organizations such as The Digital-Consultancy and the Institute of Directors. An alumnus of Heriot-Watt University with a BA in Accountancy & Computer Science and a Chartered Accountant from ICAS, Bruce Pritchard combines a robust academic background with a wealth of industry experience.